Abstract: A molecule that can permeate phospholipid bilayer membranes (cell or endosormal membranes) is a useful carrier (i.e. vector) for therapeutic drugs (especially polymeric drugs). We studied the translocation ability of the hydroxyapatite (HAp) nanoparticle poly-L-lysine (poly(Lys)) complex through negatively charged phospholipid bilayer membranes (liposomes) using several instruments. Confocal laser scanning microscopy (CLSM) confirmed that HAp-poly(Lys) complexes can translocate through phospholipid bilayer membranes and also indicated that some of the complexes were retained in the inner aqueous water layer region the liposomes after translocation.
INTRODUCTION
Hydroxyapatite (HAp) is a biomaterial that has several applications in drug delivery systems due to its chemical similarity to the inorganic phase of bones as well as its ability to adsorb and release several molecules of biological interest [1] [2] [3] [4] [5] .
The lipid bilayer of the cellular membrane acts as a barrier against permeation of various polar molecules and thus hinders the permeation of nanoparticle-based therapeutics 6, 7 . One of the strategies proposed to improve the cellular bioavailability of these therapeutic agents is to create a complex that combines these agents with cell-penetrating peptides (CPPs). Most of the recognized CPPs are derived from naturally occurring protein sequences that are endowed with the ability to cross the cell membrane and even to reach the nuclear compartment 8, 9 . In literature, CPPs have been reported to enter a variety of cells and also to enhance the cellular uptake of various macromolecular and even nanoparticulate cargos [10] [11] [12] [13] [14] [15] . Depending on the chemical nature of these cargos, different routes of cellular entry should be contemplated. It has been reported that CPPs exhibit a common uptake mechanism initialized by electrostatic interactions with the negatively charged sulfated proteoglycans and glycoproteins of the extracellular matrix, triggering endocytosis 16, 17 . Some CPPs are known to have an additional non-endocytic pathway 18, 19 .
We have reported elsewhere that cationic polymers (L-lysine, L-tyrosine copolymer, poly-L-lysine (poly(Lys)), poly-L-arginine, and polyethyrlenimine) and hydroxyapatite nanoparticle (HAp)-poly-L-arginine complexes can translocate across lipid bilayer membranes [20] [21] [22] [23] [24] .
In the present paper, we discuss the formation of the HAp-poly(Lys) complex (the surface of which is characterized by a β-sheet structure) and we study its ability to translocate through negatively charged liposome membranes. The complex was characterized with ζ potential, particle size, and Fourier transform infrared (FT-IR) spectroscopy. Translocation was investigated by analyzing the time course of fluorescence spectra and by confocal laser scanning microscopy (CLSM).
EXPERIMENTAL
Poly(Lys) (MW 35500), soybean phospholipids (SBPL), hydroxyapatite nanopowder (particle size <200 nm calculated from BET analysis), and O-phosphorylethanolamine (OPEA) were purchased from Sigma (St. Louis, MO, USA). Tris(hydroxymethyl)aminomethane (Tris) and chloroform were purchased from Kanto Chemicals Co., Tokyo, Japan. Tris-HCl buffer (10 mM, pH 7.40) was used for adjusting pH. All the reagents were used without further purification and were of analytical grade.
Fluorophore labeling
Poly(Lys) and OPEA were modified with carboxyfluorescein succinimidyl and rhodamine Red-X succinimidyl esters, respectively. For fluorophore labeling, 10 mmol/L of bicarbonate buffer solution (pH 9.0) dissolved with poly(Lys) or with OPEA was added to one of the succinimidyl esters in a N,N-dimethylformamide (DMF) solution (2 eq) and was incubated in dark overnight. The degree of substitution with respect to carboxyfluorescein was 0.9.
Formation of giant liposomes SBPL (5 mg) was dissolved in 1 ml of chloroform in a 50 ml round-bottom flask and the solvent was evaporated under a gentle nitrogen stream for 10 h to form a thin lipid film on the inner surface of the lower portion of the flask. The dried lipid film was hydrated by adding 10 ml of buffer solutions, and the flask was then sealed under argon and incubated at 20°C for 24 h. The lipid film was gradually stripped off the glass surface during incubation and it formed a giant liposome suspension 25 .
Surface modification of HAp
HAp nanoparticles (the surface of which was modified for CLSM) were prepared as mentioned previously 26 . Briefly, 100 mg of HAp nanoparticles was suspended in Tris-HCl buffer (10 mM, pH 7.40) solution containing rhodamine-labeled OPEA (0.5 × 10 -4 mol/L) and was incubated at room temperature for 3 days. The samples were washed thoroughly with pure water by centrifugation and were vacuum-dried at room temperature for 1 day.
HAp-poly(Lys) complex formation 100 mg of HAp was suspended with 5 ml of 1.0 × 10 -6 mol/L of poly(Lys) buffer. After 1 day of incubation at room temperature, the complexes were separated from the medium by means of centrifugation at 3000 rpm for 15 min. The amount of free poly(Lys) in the clear supernatant was determined by circular dichroism (CD) spectrophotometry.
Liposome-complex interactions
Secondary structure changes of the poly(Lys) moiety on the HAp surfaces were determined using FT-IR spectroscopy. Samples to be observed using FT-IR spectroscopy were prepared by mixing giant liposomes with the HAp-poly(Lys) complexes and then incubating the mixture for 3 hr at room temperature; the molar ratio of poly(Lys) to lipid was 1:2000. After incubation, the samples were separated from the aqueous medium by ultracentrifugation at 24000 rpm for 30 min and were vacuum-dried at room temperature for 1 day.
Measurement of ζ potential and particle size
The ζ potentials of HAp and of the HAp-poly(Lys) complexes were measured using a Nicomp 380 ZLS ζ potential/particle sizer (Santa Barbara, CA, USA).
Prior to measuring ζ potential, particle sizes of the HAp-poly(Lys) complexes in suspension were measured. Measurements of ζ potential and particle size were performed in a 1 × 1 cm cuvette at room temperature.
Measurements of CD spectra
The CD spectra were recorded at room temperature by using a Jasco J-600 CD spectropolarimeter with a 2 mm quartz cuvette. The spectra were averaged over nine scans.
Measurements of FT-IR spectra
FT-IR spectra were collected over the 400-4000 cm -1 wave number range at a resolution of 2 cm -1 ; 256 readings were obtained using a FT-IR/420 spectrometer (Jasco Corporation, Tokyo, Japan). The KBr (Spectroscopic grade, Aldrich Chemical, Milwaukee, WI) drifts technique was used with a KBr/sample ratio of 100:1.
Fluorescence spectroscopy
Fluorescence measurements were performed using a fluorescence spectrophotometer (FP-6600, Jasco Corporation). The excitation and emission slit widths were set at 5 µm each. The excitation wavelength was 488 nm (that for the emission scan was 500-600 nm). Measurements were performed in a 1 × 1 cm quartz cell placed in a thermostatically controlled cell holder at a temperature of 20°C. The ratio of poly(Lys) to lipids in the liposome suspension was about 1:2000.
CLSM imaging
A laser scanning confocal imaging system (LSM 410, Zeiss, Germany) with a HeNe laser (543 nm) was used for CLSM imaging. Samples were prepared by mixing giant liposomes with surface-modified HAp-poly(Lys) complexes in a glass-bottom dish (Matsunami Glass Ind., Osaka, Japan); the molar ratio of poly(Lys) to lipid was 1:2000. To prevent photobleaching, CLSM was operated under conservative laser intensity and time exposure conditions. Temperature of the observation chamber was maintained at 20°C during this process.
RESULTS
HAp-poly(Lys) complexes CD spectra were obtained for of the 1.0 × 10 -6 mol/L poly(Lys) solutions and of for the supernatants that resulted from after centrifugation of the HAp-poly(Lys) complexes. The CD spectra for the poly(Lys) buffer solution as well as for the supernatant showed minimum peaks at 195 nm and maximum peaks at around 210 nm. From the CD spectra, it was determined that the secondary structure of poly(Lys) in the buffer solution was assigned as that of a random coil. The degree of adsorption of poly(Lys) to the HAp surface was estimated to be 4.67 × 10 -8 mol/g (2.65 × 10 -3 g/g). These values were calculated based on the observed decrease in the free poly(Lys) concentration after the formation of the HAp-poly(Lys) complexes. The ζ potential is proportional to the surface charge density and, therefore, to the degree to which the cationic peptide is bound to the HAp surface. TABLE 1 shows typical data; the ζ potentials became more positive after complex formation. The mean diameter of the HAp-poly(Lys) complexes were about 10 times larger than that of the intact HAp or of the surface-modified HAp. The FT-IR spectra (1800-1500 cm −1 region) of the intact HAp and of the HAp-poly(Lys) complexes are shown in FIGURE 1. There is no absorption band for intact HAp in this region; however, there is a broad absorption band at about 1640 cm -1 (Amide I) and 1547 cm -1 (Amide II) for the HAp-poly(Lys) complex.
Liposome-complex interactions
Conformational changes of the poly(Lys) component of the HAp-poly(Lys) complex after the addition of the SBPL liposomes were investigated by recording the FT-IR spectra of the HAp-poly(Lys) complexes. The spectra of HAp-poly(Lys) complexes to which SBPL liposomes had been added showed a lipid C=O band at 1741 cm -1 (FIGURE 1c), suggesting that the addition of the SBPL vesicles affects the Amide I and II bands of the HAp-poly(Lys) complex. In addition, the 1640 cm -1 band for the HAp-poly(Lys) complex shifted to a peak of 1648 cm -1 from 1640 cm -1 upon the addition of the SBPL vesicles. 
DISCUSSION
The shift to more positive values in ζ potential that accompanies the formation of the HAp-poly(Lys) complex provides evidence that the poly(Lys) molecules are bound to the HAp surface and that positively charged amino groups are oriented at the solvent complex interface. The shift of ζ potential values and the increase in particle size that occurs after complex formation suggests that the positively charged poly(Lys) moiety, which has adsorbed to the HAp surface, forms a strong interparticle bridge, even though the net charge of the particles is positive [27] [28] [29] and the polymer segments repulse each other.
The secondary structure of the poly(Lys) component on the surface of the HAp-poly(Lys) complex
The FT-IR spectra (FIGURE 1) demonstrate that a complex is formed; clearly seen at the bands visible between 1700 and 1600 cm -1 and at approximately 1540 cm -1 . The band between 1700 and 1600 cm -1 and that at around 1540 cm -1 have been assigned amide I and Amide II bands 27, 30 . The Amide I band position shows that the conformation of the poly(Lys) moiety on the surface of the HAp-poly(Lys) complex is a β-sheet structure. The random coil structure of the unbound poly(Lys) is changed to a β-sheet structure when it comes in contact with the HAp surface. This behavior is consistent with that described in several papers dealing with protein structure rearrangements on particle surfaces that may readily form hydrogen bonds restructuring [31] [32] [33] [34] [35] . The addition of SBPL liposomes induces this secondary structure change. The polypeptide conformation of the HAp-poly(Lys) complex after the addition of the SBPL vesicles shows a mixture of β-sheet and random coil structures
Membrane translocation
The fact that the fluorescence spectra of fluorescein are strongly affected by environmental factors such as the dielectric constant (ε) has been well reported. In less polar environments, the fluorescence intensity of fluorescein decreases. Changes in the fluorescence spectra, as shown in FIGURE 2, can be classified into three stages based on the degree of interaction between the HAp-poly(Lys) complexes and the lipid membranes. The dielectric constants are about 78, 34, and 2 in the aqueous region, in the region from the lipid headgroup to the glycerol backbone, and in the center of the hydrophobic region of the liposomes, respectively 36 . In stage I, the complexes proceed electrostatically from the bulk water phase (ε = 78) to the outer surfaces and penetrate into the lipid headgroup region (ε = 34) of the liposome membranes, resulting in a gradual accumulation of the complexes in this region. In stage II, the fluorescence intensity decreases as most of the complexes pass through the hydrophobic region (ε = 2), while some remain on the membrane surface. The change in fluorescence intensity approaches a steady state in stage III, suggesting that an equilibrium has been reached between the number of complexes desorbed from and the number re-adsorbed onto the inner surface of the liposome.
CLSM images (FIGURE 3) clearly show that the HAp-poly(Lys) complex is transported across the SBPL lipid bilayer membrane and that the larger complex particles cannot enter the inner aqueous region of the liposomes. The reduction in the size of the HAp-poly(Lys) complex during the translocation process results from the breaking down of the interparticle bridges as well as from related secondary structure changes in the poly(Lys) moieties (FIGURE 1). The translocation process of the HAp-poly(Lys) complex is similar to that of the HAp-poly-L-arginine complex 23, 24 .
CONCLUSION
The HAp-poly(Lys) complex can translocate across lipid membranes when bound to a liposomal membrane. Particle size changes in the lipid environment but HAp and poly(Lys) remain tightly bound in small particles within the liposomes. The present study has focused on the process by which the HAp-poly(Lys) complex is transferred across lipid membranes. However, the results can also provide useful insights into the mechanisms by which the HAp-poly(Lys) complex interacts with biomembranes. Based on these results, we propose the use of the HAp-poly(Lys) complex as a potential vector for the delivery of therapeutic drugs to target cells.
